Generic Product News

Published Online: Wednesday, May 14, 2014
Follow Pharmacy_Times:

Capecitabine Tablets

Marketed by: Teva Pharmaceutical Industries Ltd
Compare to: Xeloda (Genentech)
Indication: Teva Pharmaceutical Industries Ltd announces the launch of capecitabine tablets, a generic equivalent to Genentech’s Xeloda. Capecitabine tablets are a metabolic inhibitor with antineoplastic activity indicated for the treatment of patients with adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer. Capecitabine tablets should be taken with water within 30 minutes after eating, and the dosage may need to be individualized to optimize patient management. Further information on dosing regimens can be found in the product’s prescribing information.
Dosage Form: Tablets: 150 and 500 mg
For More Information:

Rabeprazole Sodium Delayed-Release Tablets
Marketed by: Torrent Pharmaceuticals, Ltd
Compare to: Aciphex delayed-release tablets (Eisai, Inc)
Indication: The FDA has approved Torrent Pharmaceuticals Ltd’s rabeprazole sodium delayed-release tablets, a generic equivalent to Eisai Inc’s Aciphex delayed-release tablets. It is indicated to treat gastroesophageal reflux disease in adults and adolescents 12 years and older. It is also indicated for the healing of duodenal ulcers, Helicobacter pylori eradication to prevent duodenal ulcers, and the treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Dosage Form: Tablets: 20 mg
For More Information:

Lansoprazole Capsules, Amoxicillin Capsules, USP, and Clarithromycin Tablets, USP
Marketed by: Sandoz Inc
Compare to: PREVPAC (Takeda Pharmaceuticals, USA)
Indication: Sandoz announced the launch of lansoprazole capsules, amoxicillin capsules, USP, and clarithromycin tablets, USP—a generic version of Takeda Pharmaceuticals’ PREVPAC. It is indicated for the eradication of Helicobacter pylori infection in patients with duodenal ulcer disease. It comprises amoxicillin and clarithromycin, which are antibiotic medicines, as well as lansoprazole, a proton pump inhibitor that helps decrease the production of excess stomach acid.
Dosage Form: Lansoprazole Capsules (500 mg), Amoxicillin Capsules (500 mg), Clarithromycin Tablets (30 mg)
For More Information:

Clobetasol Propionate Foam, 0.05%, Emulsion Formulation
Marketed by: Renaissance Pharma
Compare to: Olux-E Foam (Prestium Pharma)
Indication: Renaissance Pharma introduces clobetasol propionate foam 0.05%, emulsion formulation, a generic equivalent to Prestium Pharma’s Olux-E Foam. It is a corticosteroid indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years and older. It should be applied to affected areas twice daily, in the morning and evening, for up to 2 consecutive weeks.
Dosage Form: Foam: 50 and 100 g
For More Information:

Related Articles
The FDA has granted priority review to investigational cobimetinib in combination with vemurafenib (Zelboraf) in advanced melanoma.
Vitamin D can stimulate the immune system to protect against a specific type of colorectal cancer.
The OTC antacid is being investigated for its potenial to combat colon cancer.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times